The Mitochondrion-lysosome Axis in Adaptive and Innate Immunity

Effect of Lupus Regulator Peptide P140 on Mitochondria Autophagy and NETosis

Mykolas Bendorius, Indira Neeli, Fengjuan Wang, Srinivasa Reddy Bonam, Eszter Dombi, Nelly Buron, Annie Borgne-Sanchez, Joanna Poulton, Marko Radic, Sylviane Muller

Research output: Contribution to journalArticle

Abstract

Mitochondria deserve special attention as sensors of cellular energy homeostasis and metabolic state. Moreover, mitochondria integrate intra- and extra-cellular signals to determine appropriate cellular responses that range from proliferation to cell death. In autoimmunity, as in other inflammatory chronic disorders, the metabolism of immune cells may be extensively remodeled, perturbing sensitive tolerogenic mechanisms. Here, we examine the distribution and effects of the therapeutic 21-mer peptide called P140, which shows remarkable efficacy in modulating immune responses in inflammatory settings. We measured P140 and control peptide effects on isolated mitochondria, the distribution of peptides in live cells, and their influence on the levels of key autophagy regulators. Our data indicate that while P140 targets macro- and chaperone-mediated autophagy processes, it has little effect, if any, on mitochondrial autophagy. Remarkably, however, it suppresses NET release from neutrophils exposed to immobilized NET-anti-DNA IgG complexes. Together, our results suggest that in the mitochondrion-lysosome axis, a likely driver of NETosis and inflammation, the P140 peptide does not operate by affecting mitochondria directly.

Original languageEnglish (US)
Number of pages1
JournalFrontiers in immunology
Volume9
DOIs
StatePublished - Jan 1 2018

Fingerprint

Autophagy
Adaptive Immunity
Lysosomes
Innate Immunity
Mitochondria
Immune System Diseases
Therapeutic Uses
Autoimmunity
Neutrophils
Homeostasis
Cell Death
spliceosomal peptide P140
Inflammation
Peptides
DNA

All Science Journal Classification (ASJC) codes

  • Immunology and Allergy
  • Immunology

Cite this

The Mitochondrion-lysosome Axis in Adaptive and Innate Immunity : Effect of Lupus Regulator Peptide P140 on Mitochondria Autophagy and NETosis. / Bendorius, Mykolas; Neeli, Indira; Wang, Fengjuan; Bonam, Srinivasa Reddy; Dombi, Eszter; Buron, Nelly; Borgne-Sanchez, Annie; Poulton, Joanna; Radic, Marko; Muller, Sylviane.

In: Frontiers in immunology, Vol. 9, 01.01.2018.

Research output: Contribution to journalArticle

Bendorius, Mykolas ; Neeli, Indira ; Wang, Fengjuan ; Bonam, Srinivasa Reddy ; Dombi, Eszter ; Buron, Nelly ; Borgne-Sanchez, Annie ; Poulton, Joanna ; Radic, Marko ; Muller, Sylviane. / The Mitochondrion-lysosome Axis in Adaptive and Innate Immunity : Effect of Lupus Regulator Peptide P140 on Mitochondria Autophagy and NETosis. In: Frontiers in immunology. 2018 ; Vol. 9.
@article{86b9138adf7b4eb8978a5f9ace60ff1d,
title = "The Mitochondrion-lysosome Axis in Adaptive and Innate Immunity: Effect of Lupus Regulator Peptide P140 on Mitochondria Autophagy and NETosis",
abstract = "Mitochondria deserve special attention as sensors of cellular energy homeostasis and metabolic state. Moreover, mitochondria integrate intra- and extra-cellular signals to determine appropriate cellular responses that range from proliferation to cell death. In autoimmunity, as in other inflammatory chronic disorders, the metabolism of immune cells may be extensively remodeled, perturbing sensitive tolerogenic mechanisms. Here, we examine the distribution and effects of the therapeutic 21-mer peptide called P140, which shows remarkable efficacy in modulating immune responses in inflammatory settings. We measured P140 and control peptide effects on isolated mitochondria, the distribution of peptides in live cells, and their influence on the levels of key autophagy regulators. Our data indicate that while P140 targets macro- and chaperone-mediated autophagy processes, it has little effect, if any, on mitochondrial autophagy. Remarkably, however, it suppresses NET release from neutrophils exposed to immobilized NET-anti-DNA IgG complexes. Together, our results suggest that in the mitochondrion-lysosome axis, a likely driver of NETosis and inflammation, the P140 peptide does not operate by affecting mitochondria directly.",
author = "Mykolas Bendorius and Indira Neeli and Fengjuan Wang and Bonam, {Srinivasa Reddy} and Eszter Dombi and Nelly Buron and Annie Borgne-Sanchez and Joanna Poulton and Marko Radic and Sylviane Muller",
year = "2018",
month = "1",
day = "1",
doi = "10.3389/fimmu.2018.02158",
language = "English (US)",
volume = "9",
journal = "Frontiers in Immunology",
issn = "1664-3224",
publisher = "Frontiers Media S. A.",

}

TY - JOUR

T1 - The Mitochondrion-lysosome Axis in Adaptive and Innate Immunity

T2 - Effect of Lupus Regulator Peptide P140 on Mitochondria Autophagy and NETosis

AU - Bendorius, Mykolas

AU - Neeli, Indira

AU - Wang, Fengjuan

AU - Bonam, Srinivasa Reddy

AU - Dombi, Eszter

AU - Buron, Nelly

AU - Borgne-Sanchez, Annie

AU - Poulton, Joanna

AU - Radic, Marko

AU - Muller, Sylviane

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Mitochondria deserve special attention as sensors of cellular energy homeostasis and metabolic state. Moreover, mitochondria integrate intra- and extra-cellular signals to determine appropriate cellular responses that range from proliferation to cell death. In autoimmunity, as in other inflammatory chronic disorders, the metabolism of immune cells may be extensively remodeled, perturbing sensitive tolerogenic mechanisms. Here, we examine the distribution and effects of the therapeutic 21-mer peptide called P140, which shows remarkable efficacy in modulating immune responses in inflammatory settings. We measured P140 and control peptide effects on isolated mitochondria, the distribution of peptides in live cells, and their influence on the levels of key autophagy regulators. Our data indicate that while P140 targets macro- and chaperone-mediated autophagy processes, it has little effect, if any, on mitochondrial autophagy. Remarkably, however, it suppresses NET release from neutrophils exposed to immobilized NET-anti-DNA IgG complexes. Together, our results suggest that in the mitochondrion-lysosome axis, a likely driver of NETosis and inflammation, the P140 peptide does not operate by affecting mitochondria directly.

AB - Mitochondria deserve special attention as sensors of cellular energy homeostasis and metabolic state. Moreover, mitochondria integrate intra- and extra-cellular signals to determine appropriate cellular responses that range from proliferation to cell death. In autoimmunity, as in other inflammatory chronic disorders, the metabolism of immune cells may be extensively remodeled, perturbing sensitive tolerogenic mechanisms. Here, we examine the distribution and effects of the therapeutic 21-mer peptide called P140, which shows remarkable efficacy in modulating immune responses in inflammatory settings. We measured P140 and control peptide effects on isolated mitochondria, the distribution of peptides in live cells, and their influence on the levels of key autophagy regulators. Our data indicate that while P140 targets macro- and chaperone-mediated autophagy processes, it has little effect, if any, on mitochondrial autophagy. Remarkably, however, it suppresses NET release from neutrophils exposed to immobilized NET-anti-DNA IgG complexes. Together, our results suggest that in the mitochondrion-lysosome axis, a likely driver of NETosis and inflammation, the P140 peptide does not operate by affecting mitochondria directly.

UR - http://www.scopus.com/inward/record.url?scp=85054890982&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85054890982&partnerID=8YFLogxK

U2 - 10.3389/fimmu.2018.02158

DO - 10.3389/fimmu.2018.02158

M3 - Article

VL - 9

JO - Frontiers in Immunology

JF - Frontiers in Immunology

SN - 1664-3224

ER -